Clinical value of serum neuroplasticity mediators in identifying the central sensitivity syndrome in patients with chronic pain with and without structural pathology

Clinical Journal of Pain

Volumn 31, Issue 11, 2015, Pages 959-967

  Deitos, Alicia ^a,b   Dussán Sarria, Jairo A ^a,b   De Souza, Andressa ^a,b,c   Medeiros, Liciane ^a,b   Da Graça Tarragô, Maria ^a,b,d   Sehn, Francislea ^a,b   Chassot, Mônica ^a,b   Zanette, Simone ^a,b,d   Schwertner, Andre ^a,b   Fregni, Felipe ^a,e,f   Torres, Iraci L S ^a,b,g   Caumo, Wolnei ^a,b,h,i  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Mestrado em Avaliacao de Impactos Ambientais em Mineracao Victor Barreto   (Brazil)

^d Physical Medicine and Rehabilitation Service   (Brazil)

^e Plastic Surgery Department Porto Alegre Clinics Hospital (HCPA)   (Brazil)

^f Pharmacology Department Instituto de Ciê Ncias Bá Sicas da Saú de   (Brazil)

^g and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^h Departments of Rehabilitation Sciences Physical Medicine and Rehabilitation and Neurosciences   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BDNF; Central sensitivity syndrome; Chronic pain; Cytokines; Plasticity; TNF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; CENTRAL SENSITIVITY SYNDROME; CHRONIC PAIN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NOCICEPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; VISUAL ANALOG SCALE; BLOOD; ENDOMETRIOSIS; FIBROMYALGIA; MIDDLE AGED; MYOFASCIAL PAIN; NERVE CELL PLASTICITY; OSTEOARTHRITIS; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TENSION HEADACHE;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; DEPRESSION; ENDOMETRIOSIS; FEMALE; FIBROMYALGIA; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MIDDLE AGED; MYOFASCIAL PAIN SYNDROMES; NEURONAL PLASTICITY; OSTEOARTHRITIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TENSION-TYPE HEADACHE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84943199728     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0000000000000194     Document Type: Article

References (47)

1. Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008;37:339-352.
2. Gwilym SE, Keltner JR, Warnaby CE, et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum. 2009;61:1226-1234.
3. Kaya S, Hermans L, Willems T, et al. Central sensitization in urogynecological chronic pelvic pain: a systematic literature review. Pain Phys. 2013;16:291-308.
4. Skou ST, Graven-Nielsen T, Rasmussen S, et al. Facilitation of pain sensitization in knee osteoarthritis and persistent postoperative pain: a cross-sectional study. Eur J Pain. 2014;18: 1024-1031.
5. Wylde V, Palmer S, Learmonth ID, et al. The association between pre-operative pain sensitisation and chronic pain after knee replacement: an exploratory study. Osteoarthritis Cartilage. 2013;21:1253-1256.
6. Suokas AK, Walsh DA, McWilliams DF, et al. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2012;20:1075-1085.
7. Pavlakovic G, Petzke F. The role of quantitative sensory testing in the evaluation of musculoskeletal pain conditions. Curr Rheumatol Rep. 2010;12:455-461.
8. Bajaj P, Graven-Nielsen T, Arendt-Nielsen L. Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain. 2001;93:107-114.
9. Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149:573-581.
10. Arendt-Nielsen L, Eskehave TN, Egsgaard LL, et al. Association between experimental pain biomarkers and serological markers in patients with different degree of painful knee osteoarthritis. Arthritis Rheumatol. 2014;66:3317-3326.
11. Bajaj P, Madsen H, Arendt-Nielsen L. Endometriosis is associated with central sensitization: a psychophysical controlled study. J Pain. 2003;4:372-380.
12. Volz MS, Medeiros LF, G Tarrago Ma, et al. The relationship between cortical excitability and pain catastrophizing in myofascial pain. J Pain. 2013;14:1140-1147.
13. Neblett R, Cohen H, Choi Y, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14:438-445.
14. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10:895-926.
15. Kawasaki Y, Zhang L, Cheng JK, et al. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008;28:5189-5194.
16. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004;22:123-131.
17. Sheng WS, Hu S, Kravitz FH, et al. Tumor necrosis factor alpha upregulates human microglial cell production of inter-leukin-10 in vitro. Clin Diagn Lab Immunol. 1995;2:604-608.
18. Ledeboer A, Breve JJ, Poole S, et al. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia. 2000;30:134-142.
19. Bazzichi L, Rossi A, Massimetti G, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol. 2007;25:225-230.
20. Bø SH, Davidsen EM, Gulbrandsen P, et al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. 2009;29:365-372.
21. Vidor LP, Torres IL, Medeiros LF, et al. Association of anxiety with intracortical inhibition and descending pain modulation in chronic myofascial pain syndrome. BMC Neurosci. 2014;15:42.
22. Zanette SA, Dussan-Sarria JA, Souza A, et al. Higher serum S100B and BDNF levels are correlated with a lower pressure-pain threshold in fibromyalgia. Mol Pain. 2014;10:46, Available at: http://www.molecularpain.com/content/10/1/46.
23. Palos GR, Mendoza TR, Mobley GM, et al. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006;7:49-56.
24. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840.
25. Jinks C, Jordan K, Croft P. Measuring the population impact of knee pain and disability with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Pain. 2002;100:55-64.
26. Nebel MB, Sims EL, Keefe FJ, et al. The relationship of self-reported pain and functional impairment to gait mechanics in overweight and obese persons with knee osteoarthritis. Arch Phys Med Rehabil. 2009;90:1874-1879.
27. Simons DG. New views of myofascial trigger points: etiology and diagnosis. Arch Phys Med Rehabil. 2008;89:157-159.
28. Society HCSotIH. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(suppl 1):9-160.
29. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-172.
30. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34: 505-514.
31. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:499-505.
32. Sehn F, Chachamovich E, Vidor LP, et al. Cross-cultural adaptation and validation of the Brazilian Portuguese version of the pain catastrophizing scale. Pain Med. 2012;13: 1425-1435.
33. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain. 2012;153: 1148-1158.
34. Pan W, Kastin AJ. TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol. 2002;174:193-200.
35. Pan W, Banks WA, Fasold MB, et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37:1553-1561.
36. Rasmussen P, Brassard P, Adser H, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009;94:1062-1069.
37. de Vries HE, Blom-Roosemalen MC, van Oosten M, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64:37-43.
38. Fischer M, Wille G, Klien S, et al. Brain-derived neurotrophic factor in primary headaches. J Headache Pain. 2012;13: 469-475.
39. Laske C, Stransky E, Eschweiler GW, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res. 2007;41:600-605.
40. Gomes WF, Lacerda AC, Mendonça VA, et al. Effect of exercise on the plasma BDNF levels in elderly women with knee osteoarthritis. Rheumatol Int. 2014;34:841-846.
41. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44: 1237-1247.
42. Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford Study. Arthritis Rheum. 2009;60:2037-2045.
43. Stannus O, Jones G, Cicuttini F, et al. Circulating levels of IL-6 and TNF-a are associated with knee radiographic osteo-arthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage. 2010;18:1441-1447.
44. Carmona F, Chapron C, Martinez-Zamora MA, et al. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immuno. 2012;95:80-86. doi: 10.1016/j.jri.2012.06.001.
45. Flatters SJ, Fox AJ, Dickenson AH. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res. 2003;984:54-62.
46. Nugraha B, Korallus C, Gutenbrunner C. Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int. 2013;62:281-286.
47. Stefani LC, Torres IL, de Souza IC, et al. BDNF as an effect modifier for gender effects on pain thresholds in healthy subjects. Neurosci Lett. 2012;514:62-66.